Immune-based strategies for mood disorders: facts and challenges

References

• Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama. 2003 Jun 18;289(23):3095–3105. PubMed PMID: 12813115.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Merikangas KR, Wang PS. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol. 2007;3:137–158. PubMed PMID: 17716051.
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011 Mar;68(3):241–251. PubMed PMID: 21383262; PubMed Central PMCID: PMCPmc3486639.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry. 2006 Sep;163(9):1561–1568. PubMed PMID: 16946181; PubMed Central PMCID: PMCPmc1924724.
   PubMed Web of Science ®Google Scholar
• Kessler RC. The costs of depression. Psychiatr Clin North Am. 2012 Mar;35(1):1–14. DOI:10.1016/j.psc.2011.11.005
   PubMed Web of Science ®Google Scholar
• Ferrari AJ, Norman RE, Freedman G, et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010. PloS One. 2014;9(4):e91936. PubMed PMID: 24694747; PubMed Central PMCID: PMCPmc3973668. DOI:10.1371/journal.pone.0091936.
   PubMed Web of Science ®Google Scholar
• Bolton JM, Gunnell D, Turecki G. Suicide risk assessment and intervention in people with mental illness. BMJ. 2015 Nov 09;351:h4978. PubMed PMID: 26552947. DOI:10.1136/bmj.h4978.
   PubMedGoogle Scholar
• Goldstein BI, Carnethon MR, Matthews KA, et al. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015 Sep 08;132(10):965–986. PubMed PMID: 26260736.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006 Nov;163(11):1905–1917. PubMed PMID: 17074942.
   PubMed Web of Science ®Google Scholar
• Souery D, Papakostas GI, Trivedi MH. Treatment-resistant depression. J Clin Psychiatry. 2006;67(Suppl 6):16–22. PubMed PMID: 16848672.
   PubMed Web of Science ®Google Scholar
• Murrough JW, Wade E, Sayed S, et al. Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: a proof of concept clinical trial. J Affect Disord. 2017 Aug 15;218:277–283. PubMed PMID: 28478356. DOI:10.1016/j.jad.2017.04.072.
   PubMed Web of Science ®Google Scholar
• Pangalos MN, Schechter LE, Hurko O. Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nat Rev Drug Discov. 2007 Jul;6(7):521–532. PubMed PMID: 17599084. DOI:10.1038/nrd2094.
   PubMed Web of Science ®Google Scholar
• Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006 Feb;7(2):137–151. PubMed PMID: 16429123. DOI:10.1038/nrn1846.
   PubMed Web of Science ®Google Scholar
• Papakostas GI, Ionescu DF. Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder. Mol Psychiatry. 2015 Oct;20(10):1142–1150. PubMed PMID: 26148812. DOI:10.1038/mp.2015.92.
   PubMed Web of Science ®Google Scholar
• Caban A, Pisarczyk K, Kopacz K, et al. Filling the gap in CNS drug development: evaluation of the role of drug repurposing. J Mark Access Health Policy. 2017;5(1):1299833. PubMed PMID: 28473889; PubMed Central PMCID: PMCPmc5405562. DOI:10.1080/20016689.2017.1299833.
   PubMedGoogle Scholar
• Teixeira AL, Muller N. Immunology of psychiatric disorders. Neuroimmunomodulation. 2014;21(2–3):71. PubMed PMID: 24557037.
   PubMed Web of Science ®Google Scholar
• Noto C, Rizzo LB, Mansur RB, et al. Targeting the inflammatory pathway as a therapeutic tool for major depression. Neuroimmunomodulation. 2014;21(2–3):131–139. PubMed PMID: 24557046. DOI:10.1159/000356549.
   PubMed Web of Science ®Google Scholar
• Haapakoski R, Ebmeier KP, Alenius H, et al. Innate and adaptive immunity in the development of depression: an update on current knowledge and technological advances. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Apr 03;66:63–72. PubMed PMID: 26631274; PubMed Central PMCID: PMCPmc4736094. DOI:10.1016/j.pnpbp.2015.11.012.
   PubMed Web of Science ®Google Scholar
• Sayana P, Colpo GD, Simoes LR, et al. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. J Psychiatr Res. 2017 Sep;92:160–182. PubMed PMID: 28458141.
   PubMed Web of Science ®Google Scholar
• Schmidt FM, Lichtblau N, Minkwitz J, et al. Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J Psychiatr Res. 2014 Aug;55:29–34. PubMed PMID: 24838047.
   PubMed Web of Science ®Google Scholar
• Dahl J, Ormstad H, Aass HC, et al. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology. 2014 Jul;45:77–86. PubMed PMID: 24845179. DOI:10.1016/j.psyneuen.2014.03.019.
   PubMed Web of Science ®Google Scholar
• Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine. 2009 Feb;71(2):171–186. PubMed PMID: 19188531. DOI:10.1097/PSY.0b013e3181907c1b.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012 Aug;139(3):230–239. PubMed PMID: 21872339. DOI:10.1016/j.jad.2011.08.003.
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010 Mar 01;67(5):446–457. PubMed PMID: 20015486.
   PubMed Web of Science ®Google Scholar
• Courtet P, Jaussent I, Genty C, et al. Increased CRP levels may be a trait marker of suicidal attempt. European Neuropsychopharmacology. 2015 Oct;25(10):1824–1831. PubMed PMID: 26032768.
   PubMed Web of Science ®Google Scholar
• O’Donovan A, Rush G, Hoatam G, et al. Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anxiety. 2013 Apr;30(4):307–314. PubMed PMID: 23504697.
   PubMed Web of Science ®Google Scholar
• Levine J, Barak Y, Chengappa KN, et al. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology. 1999 Nov;40(4):171–176. PubMed PMID: 10559698.
   PubMed Web of Science ®Google Scholar
• Stubner S, Schon T, Padberg F, et al. Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130. Neuroscience Letters. 1999 Jan 15;259(3):145–148. PubMed PMID: 10025579.
   PubMed Web of Science ®Google Scholar
• Carpenter LL, Heninger GR, Malison RT, et al. Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression. J Affect Disord. 2004 Apr;79(1–3):285–289. PubMed PMID: 15023509.
   PubMed Web of Science ®Google Scholar
• Dean B, Gibbons AS, Tawadros N, et al. Different changes in cortical tumor necrosis factor-alpha-related pathways in schizophrenia and mood disorders. Mol Psychiatry. 2013 Jul;18(7):767–773. PubMed PMID: 22801413.
   PubMed Web of Science ®Google Scholar
• Kim S, Hwang Y, Webster MJ, et al. Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders. Mol Psychiatry. 2016 Mar;21(3):376–385. PubMed PMID: 26077692.
   PubMed Web of Science ®Google Scholar
• Torres-Platas SG, Cruceanu C, Chen GG, et al. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun. 2014 Nov;42:50–59. PubMed PMID: 24858659.
   PubMed Web of Science ®Google Scholar
• Setiawan E, Wilson AA, Mizrahi R, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry. 2015 Mar;72(3):268–275. PubMed PMID: 25629589; PubMed Central PMCID: PMCPmc4836849.
   PubMed Web of Science ®Google Scholar
• Walsh JG, Muruve DA, Power C. Inflammasomes in the CNS. Nature Reviews Neuroscience. 2014 Feb;15(2):84–97. PubMed PMID: 24399084. DOI:10.1038/nrn3638.
   PubMed Web of Science ®Google Scholar
• Sousa C, Biber K, Michelucci A. Cellular and molecular characterization of microglia: a unique immune cell population. Front Immunol. 2017;8:198. PubMed PMID: 28303137; PubMed Central PMCID: PMC5332364. DOI:10.3389/fimmu.2017.00198.
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Derecki NC, Lovenberg TW, et al. Role of neuro-immunological factors in the pathophysiology of mood disorders. Psychopharmacology. 2016 May;233(9):1623–1636. PubMed PMID: 26803500.
   PubMed Web of Science ®Google Scholar
• Bitzer-Quintero OK, Gonzalez-Burgos I. Immune system in the brain: a modulatory role on dendritic spine morphophysiology? Neural Plast. 2012;2012:348642. PubMed PMID: 22548192; PubMed Central PMCID: PMC3324176. DOI:10.1155/2012/348642.
   PubMed Web of Science ®Google Scholar
• Patel JP, Frey BN. Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder? Neural Plast. 2015;2015:708306. PubMed PMID: 26075104; PubMed Central PMCID: PMCPmc4444594. DOI:10.1155/2015/708306.
   PubMed Web of Science ®Google Scholar
• Dantzer R, Konsman JP, Bluthe RM, et al. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci. 2000 Dec 20;85(1–3):60–65. PubMed PMID: 11189027.
   PubMed Web of Science ®Google Scholar
• D’Mello C, Le T, Swain MG. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci. 2009 Feb 18;29(7):2089–2102. PubMed PMID: 19228962. DOI:10.1523/jneurosci.3567-08.2009.
   PubMed Web of Science ®Google Scholar
• Menard C, Hodes GE, Russo SJ. Pathogenesis of depression: insights from human and rodent studies. Neuroscience. 2016 May 03;321:138–162. PubMed PMID: 26037806; PubMed Central PMCID: PMCPmc4664582. DOI:10.1016/j.neuroscience.2015.05.053.
   PubMed Web of Science ®Google Scholar
• Korczak DJ, Pereira S, Koulajian K, et al. Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link. Diabetologia. 2011 Oct;54(10):2483–2493. PubMed PMID: 21789690.
   PubMed Web of Science ®Google Scholar
• Vonk R, Van Der Schot AC, Kahn RS, et al. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder? Biol Psychiatry. 2007 Jul 15;62(2):135–140. PubMed PMID: 17141745.
   PubMed Web of Science ®Google Scholar
• Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosomatic Medicine. 2003 Mar-Apr;65(2):201–210. PubMed PMID: 12651987.
   PubMed Web of Science ®Google Scholar
• Van Der Kooy K, Van Hout H, Marwijk H, et al. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Ger Psychiatry. 2007 Jul;22(7):613–626. PubMed PMID: 17236251.
   PubMed Web of Science ®Google Scholar
• Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med. 2002 Jul;23(1):51–61. PubMed PMID: 12093424.
   PubMed Web of Science ®Google Scholar
• Valkanova V. Ebmeier KP. Vascular risk factors and depression in later life: a systematic review and meta-analysis. Biol Psychiatry. 2013 Mar 01;73(5):406–413. PubMed PMID: 23237315. DOI:10.1016/j.biopsych.2012.10.028.
   PubMed Web of Science ®Google Scholar
• Kunugi H, Hori H, Ogawa S. Biochemical markers subtyping major depressive disorder. Psychiatry Clin Neurosci. 2015 Oct;69(10):597–608. PubMed PMID: 25825158. DOI:10.1111/pcn.12299.
   PubMed Web of Science ®Google Scholar
• Gold PW. The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry. 2015 Feb;20(1):32–47. PubMed PMID: 25486982. DOI:10.1038/mp.2014.163.
   PubMed Web of Science ®Google Scholar
• Lamers F, Vogelzangs N, Merikangas KR, et al. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry. 2013 Jun;18(6):692–699. PubMed PMID: 23089630.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Seeman TE, Bower JE, et al. Prospective association between C-reactive protein and fatigue in the coronary artery risk development in young adults study. Biol Psychiatry. 2009 Nov 01;66(9):871–878. PubMed PMID: 19640510; PubMed Central PMCID: PMC2763037.
   PubMed Web of Science ®Google Scholar
• Capuron L, Su S, Miller AH, et al. Depressive symptoms and metabolic syndrome: is inflammation the underlying link?Biol Psychiatry. 2008 Nov 15;64(10):896–900. PubMed PMID: 18597739; PubMed Central PMCID: PMC2621309.
   PubMed Web of Science ®Google Scholar
• Soderlund J, Olsson SK, Samuelsson M, et al. Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder. J Psychiatry Neurosci: JPN. 2011 Mar;36(2):114–118. PubMed PMID: 21138659; PubMed Central PMCID: PMCPmc3044194.
   PubMed Web of Science ®Google Scholar
• Rolstad S, Jakobsson J, Sellgren C, et al. CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment. European Neuropsychopharmacology. 2015 Aug;25(8):1091–1098. PubMed PMID: 26024928.
   PubMed Web of Science ®Google Scholar
• Jakobsson J, Bjerke M, Sahebi S, et al. Monocyte and microglial activation in patients with mood-stabilized bipolar disorder. J Psychiatry Neurosci: JPN. 2015 Jul;40(4):250–258. PubMed PMID: 25768030; PubMed Central PMCID: PMCPmc4478058.
   PubMed Web of Science ®Google Scholar
• Brietzke E, Kauer-Sant’Anna M, Teixeira AL, et al. Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder. Brain Behav Immun. 2009 Nov;23(8):1079–1082. PubMed PMID: 19406226.
   PubMed Web of Science ®Google Scholar
• Brietzke E, Stertz L, Fernandes BS, et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord. 2009 Aug;116(3):214–217. PubMed PMID: 19251324.
   PubMed Web of Science ®Google Scholar
• Maes M, Bosmans E, Calabrese J, et al. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 1995 Mar-Apr;29(2):141–152. PubMed PMID: 7666381.
   PubMed Web of Science ®Google Scholar
• Kim YK, Jung HG, Myint AM, et al. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord. 2007 Dec;104(1–3):91–95. PubMed PMID: 17434599.
   PubMed Web of Science ®Google Scholar
• O’Brien SM, Scully P, Scott LV, et al. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord. 2006 Feb;90(2–3):263–267. PubMed PMID: 16410025.
   PubMed Web of Science ®Google Scholar
• Ortiz-Dominguez A, Hernandez ME, Berlanga C, et al. Immune variations in bipolar disorder: phasic differences. Bipolar Disord. 2007 Sep;9(6):596–602. PubMed PMID: 17845274.
   PubMed Web of Science ®Google Scholar
• Padmos RC, Hillegers MH, Knijff EM, et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry. 2008 Apr;65(4):395–407. PubMed PMID: 18391128.
   PubMed Web of Science ®Google Scholar
• Breunis MN, Kupka RW, Nolen WA, et al. High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biol Psychiatry. 2003 Jan 15;53(2):157–165. PubMed PMID: 12547472.
   PubMed Web of Science ®Google Scholar
• Tsai SY, Yang YY, Kuo CJ, et al. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania. J Affect Disord. 2001 May;64(2–3):185–193. PubMed PMID: 11313085.
   PubMed Web of Science ®Google Scholar
• Tsai SY, Chen KP, Yang YY, et al. Activation of indices of cell-mediated immunity in bipolar mania. Biol Psychiatry. 1999 Apr 15;45(8):989–994. PubMed PMID: 10386181.
   PubMed Web of Science ®Google Scholar
• Cunha AB, Andreazza AC, Gomes FA, et al. Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2008 Aug;258(5):300–304. PubMed PMID: 18297417.
   PubMed Web of Science ®Google Scholar
• Huang TL, Lin FC. High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):370–372. PubMed PMID: 17064834. DOI:10.1016/j.pnpbp.2006.09.010.
   PubMed Web of Science ®Google Scholar
• Wadee AA, Kuschke RH, Wood LA, et al. Serological observations in patients suffering from acute manic episodes. Hum Psychopharmacol. 2002 Jun;17(4):175–179. PubMed PMID: 12404684.
   PubMed Web of Science ®Google Scholar
• Tsai SY, Chung KH, Wu JY, et al. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder. J Affect Disord. 2012 Jan;136(1–2):110–116. PubMed PMID: 21962564.
   PubMed Web of Science ®Google Scholar
• Rao JS, Harry GJ, Rapoport SI, et al. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 2010 Apr;15(4):384–392. PubMed PMID: 19488045; PubMed Central PMCID: PMCPmc2844920. DOI:10.1038/mp.2009.47.
   PubMed Web of Science ®Google Scholar
• Haarman BC, Riemersma-Van Der Lek RF, De Groot JC, et al. Neuroinflammation in bipolar disorder - A [(11)C]-(R)-PK11195 positron emission tomography study. Brain Behav Immun. 2014 Aug;40:219–225. PubMed PMID: 24703991.
   PubMed Web of Science ®Google Scholar
• Haarman BC, Burger H, Doorduin J, et al. Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study. Brain Behav Immun. 2016 Aug;56:21–33. PubMed PMID: 26348581.
   PubMed Web of Science ®Google Scholar
• Pandey GN, Ren X, Rizavi HS, et al. Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder. Bipolar Disord. 2015 Sep;17(6):636–644. PubMed PMID: 26257203; PubMed Central PMCID: PMCPmc4940117.
   PubMed Web of Science ®Google Scholar
• Barbosa IG, Rocha NP, Assis F, et al. Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders. Int J Neuropsychopharmacol. 2014 Oct 31;18(1). PubMed PMID: 25539506; PubMed Central PMCID: PMCPmc4368866. DOI:10.1093/ijnp/pyu021.
   PubMed Web of Science ®Google Scholar
• Barbosa IG, Nogueira CR, Rocha NP, et al. Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD patients. J Psychiatr Res. 2013 Dec;47(12):1949–1954. PubMed PMID: 2407532.
   PubMed Web of Science ®Google Scholar
• SayuriYamagata A, Brietzke E, Rosenblat JD, et al. Medical comorbidity in bipolar disorder: the link with metabolic-inflammatory systems. J Affect Disord. 2017 Mar 15;211:99–106. PubMed PMID: 28107669. DOI:10.1016/j.jad.2016.12.059.
   PubMed Web of Science ®Google Scholar
• Hillegers MH, Reichart CG, Wals M, et al. Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parents. European Neuropsychopharmacology. 2007 May-Jun;17(6–7):394–399. PubMed PMID: 17140771.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Okusaga OO, Quevedo J, et al. The potential association between obesity and bipolar disorder: a meta-analysis. J Affect Disord. 2016 Sep 15;202:120–123. PubMed PMID: 27262632. DOI:10.1016/j.jad.2016.05.059.
   PubMed Web of Science ®Google Scholar
• Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003 Jun 15;110(5–6):255–258. PubMed PMID: 14592543.
   PubMed Web of Science ®Google Scholar
• Abbasi SH, Hosseini F, Modabbernia A, et al. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord. 2012 Dec 10;141(2–3):308–314. PubMed PMID: 22516310.
   PubMed Web of Science ®Google Scholar
• Muller N, Schwarz MJ, Dehning S, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry. 2006 Jul;11(7):680–684. PubMed PMID: 16491133.
   PubMed Web of Science ®Google Scholar
• Akhondzadeh S, Jafari S, Raisi F, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety. 2009;26(7):607–611. PubMed PMID: 19496103. DOI:10.1002/da.20589.
   PubMed Web of Science ®Google Scholar
• Nery FG, Monkul ES, Hatch JP, et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Human Psychopharmacology. 2008 Mar;23(2):87–94. PubMed PMID: 18172906.
   PubMed Web of Science ®Google Scholar
• Maes M. Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression. Metab Brain Dis. 2012 Dec;27(4):405–413. PubMed PMID: 22773310. DOI:10.1007/s11011-012-9326-6.
   PubMed Web of Science ®Google Scholar
• Cipollone F, Patrignani P, Greco A, et al. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation. 1997 Aug 19;96(4):1109–1116. PubMed PMID: 9286937.
   PubMed Web of Science ®Google Scholar
• Chandrasekharan JA, Sharma-Walia N. Lipoxins: nature’s way to resolve inflammation. J Inflamm Res. 2015;8:181–192. PubMed PMID: 26457057; PubMed Central PMCID: PMCPmc4598198. DOI:10.2147/jir.s90380.
   PubMed Web of Science ®Google Scholar
• Mendlewicz J, Kriwin P, Oswald P, et al. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol. 2006 Jul;21(4):227–231. PubMed PMID: 16687994.
   PubMed Web of Science ®Google Scholar
• Almeida OP, Alfonso H, Jamrozik K, et al. Aspirin use, depression, and cognitive impairment in later life: the health in men study. J Am Geriatr Soc. 2010 May;58(5):990–992. PubMed PMID: 20722830.
   PubMed Web of Science ®Google Scholar
• Stolk P, Souverein PC, Wilting I, et al. Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins Leukot Essent Fatty Acids. 2010 Jan;82(1):9–14. PubMed PMID: 19939659; PubMed Central PMCID: PMCPmc2818404.
   PubMed Web of Science ®Google Scholar
• Levine J, Cholestoy A, Zimmerman J. Possible antidepressant effect of minocycline. Am J Psychiatry. 1996 Apr;153(4):582. PubMed PMID: 8599421.
   PubMed Web of Science ®Google Scholar
• Soczynska JK, Mansur RB, Brietzke E, et al. Novel therapeutic targets in depression: minocycline as a candidate treatment. Behav Brain Res. 2012 Dec 01;235(2):302–317. PubMed PMID: 22963995.
   PubMed Web of Science ®Google Scholar
• Homsi S, Federico F, Croci N, et al. Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. Brain Res. 2009 Sep 29;1291:122–132. PubMed PMID: 19631631. DOI:10.1016/j.brainres.2009.07.031.
   PubMed Web of Science ®Google Scholar
• Kim SS, Kong PJ, Kim BS, et al. Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells. Arch Pharm Res. 2004 Mar;27(3):314–318. PubMed PMID: 15089037.
   PubMed Web of Science ®Google Scholar
• Tomas-Camardiel M, Rite I, Herrera AJ, et al. Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis. 2004 Jun;16(1):190–201. PubMed PMID: 15207276.
   PubMed Web of Science ®Google Scholar
• Miyaoka T, Wake R, Furuya M, et al. Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jun 01;37(2):222–226. PubMed PMID: 22349578.
   PubMed Web of Science ®Google Scholar
• Dantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008 Jan;9(1):46–56. PubMed PMID: 18073775; PubMed Central PMCID: PMCPmc2919277. DOI:10.1038/nrn2297.
   PubMed Web of Science ®Google Scholar
• Ertenli I, Ozer S, Kiraz S, et al. Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Rheumatol Int. 2012 Feb;32(2):323–330. PubMed PMID: 21079965.
   PubMed Web of Science ®Google Scholar
• Feldman SR, Gottlieb AB, Bala M, et al. Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis. Br J Dermatol. 2008 Sep;159(3):704–710. PubMed PMID: 18627375.
   PubMed Web of Science ®Google Scholar
• Persoons P, Vermeire S, Demyttenaere K, et al. The impact of major depressive disorder on the short- and long-term outcome of Crohn’s disease treatment with infliximab. Aliment Pharmacol Ther. 2005 Jul 15;22(2):101–110. PubMed PMID: 16011668.
   PubMed Web of Science ®Google Scholar
• Kappelmann N, Lewis G, Dantzer R, et al. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry. 2016 Oct 18. PubMed PMID: 27752078. DOI:10.1038/mp.2016.167.
   PubMedGoogle Scholar
• Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013 Jan;70(1):31–41. PubMed PMID: 22945416; PubMed Central PMCID: PMCPmc4015348.
   PubMed Web of Science ®Google Scholar
• Atzeni F, Talotta R, Salaffi F, et al. Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmun Rev. 2013 May;12(7):703–708. PubMed PMID: 23207283.
   PubMed Web of Science ®Google Scholar
• Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. Jama. 2006 May 17;295(19):2275–2285. PubMed PMID: 16705109.
   PubMed Web of Science ®Google Scholar
• Van Dartel SA, Fransen J, Kievit W, et al. Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Ann Rheum Dis. 2013 Jun;72(6):895–900. PubMed PMID: 22887849.
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991 Sep;54(3):438–463. PubMed PMID: 1908631.
   PubMed Web of Science ®Google Scholar
• Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res. 2008 Aug;52(8):885–897. PubMed PMID: 18504706. DOI:10.1002/mnfr.200700289.
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser JK, Belury MA, Andridge R, et al. Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav Immun. 2012 Aug;26(6):988–995. PubMed PMID: 22640930; PubMed Central PMCID: PMCPmc3398219.
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser JK, Belury MA, Andridge R, et al. Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun. 2011 Nov;25(8):1725–1734. PubMed PMID: 21784145; PubMed Central PMCID: PMCPmc3191260.
   PubMed Web of Science ®Google Scholar
• Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr. 2010 Mar;91(3):757–770. PubMed PMID: 20130098. DOI:10.3945/ajcn.2009.28313.
   PubMed Web of Science ®Google Scholar
• Martins JG, Bentsen H, Puri BK. Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis. Mol Psychiatry. 2012 Dec;17(12):1144–1149; discussion 1163-7. PubMed PMID: 22488258. DOI:10.1038/mp.2012.25.
   PubMed Web of Science ®Google Scholar
• Gertsik L, Poland RE, Bresee C, et al. Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol. 2012 Feb;32(1):61–64. PubMed PMID: 22198441; PubMed Central PMCID: PMCPmc3375825.
   PubMed Web of Science ®Google Scholar
• Jazayeri S, Tehrani-Doost M, Keshavarz SA, et al. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust N Z J Psychiatry. 2008 Mar;42(3):192–198. PubMed PMID: 18247193.
   PubMed Web of Science ®Google Scholar
• Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002 Oct;59(10):913–919. PubMed PMID: 12365878.
   PubMed Web of Science ®Google Scholar
• Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999 May;56(5):407–412. PubMed PMID: 10232294.
   PubMed Web of Science ®Google Scholar
• Hirashima F, Parow AM, Stoll AL, et al. Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. Am J Psychiatry. 2004 Oct;161(10):1922–1924. PubMed PMID: 15465995.
   PubMed Web of Science ®Google Scholar
• Keck PE Jr., Mintz J, McElroy SL, et al. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry. 2006 Nov 01;60(9):1020–1022. PubMed PMID: 16814257.
   PubMed Web of Science ®Google Scholar
• Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry. 2006 Jan;188:46–50. PubMed PMID: 16388069.
   PubMed Web of Science ®Google Scholar
• Frangou S, Lewis M, Wollard J, et al. Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol (Oxford, England). 2007 Jun;21(4):435–439. PubMed PMID: 16891338.
   PubMed Web of Science ®Google Scholar
• Chiu CC, Huang SY, Chen CC, et al. Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder. J Clin Psychiatry. 2005 Dec;66(12):1613–1614. PubMed PMID: 16401167.
   PubMed Web of Science ®Google Scholar
• Jacka FN, O’Neil A, Opie R, et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Med. 2017 Jan 30;15(1):23. PubMed PMID: 28137247; PubMed Central PMCID: PMCPmc5282719.
   PubMed Web of Science ®Google Scholar
• Liu X, Yan Y, Li F, et al. Fruit and vegetable consumption and the risk of depression: a meta-analysis. Nutrition (Burbank, Los Angeles County, Calif). 2016 Mar;32(3):296–302. PubMed PMID: 26691768.
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets. 2007 Jun;6(3):219–233. PubMed PMID: 17511618; PubMed Central PMCID: PMCPmc2918806.
   PubMedGoogle Scholar
• Tsai GY, Cui JZ, Syed H, et al. Effect of N-acetylcysteine on the early expression of inflammatory markers in the retina and plasma of diabetic rats. Clin Exp Ophthalmol. 2009 Mar;37(2):223–231. PubMed PMID: 19723131; PubMed Central PMCID: PMCPmc3947378.
   PubMed Web of Science ®Google Scholar
• Kigerl KA, Ankeny DP, Garg SK, et al. System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo. Exp Neurol. 2012 Jan;233(1):333–341. PubMed PMID: 22079587; PubMed Central PMCID: PMCPmc3268895.
   PubMed Web of Science ®Google Scholar
• Berk M, Dean OM, Cotton SM, et al. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry. 2014 Jun;75(6):628–636. PubMed PMID: 25004186.
   PubMed Web of Science ®Google Scholar
• Berk M, Copolov DL, Dean O, et al. N-acetyl cysteine for depressive symptoms in bipolar disorder–a double-blind randomized placebo-controlled trial. Biol Psychiatry. 2008 Sep 15;64(6):468–475. PubMed PMID: 18534556.
   PubMed Web of Science ®Google Scholar
• Berk M, Dean O, Cotton SM, et al. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord. 2011 Dec;135(1–3):389–394. PubMed PMID: 21719110.
   PubMed Web of Science ®Google Scholar
• Mora S, Cook N, Buring JE, et al. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation. 2007 Nov 06;116(19):2110–2118. PubMed PMID: 17967770; PubMed Central PMCID: PMC2117381.
   PubMed Web of Science ®Google Scholar
• Schuch FB, Vancampfort D, Rosenbaum S, et al. Exercise for depression in older adults: a meta-analysis of randomized controlled trials adjusting for publication bias. Rev Bras Psiquitar. 2016 Jul-Sep;38(3):247–254. PubMed PMID: 27611903.
   PubMed Web of Science ®Google Scholar
• Pereira DS, Mateo EC, De Queiroz BZ, et al. TNF-alpha, IL6, and IL10 polymorphisms and the effect of physical exercise on inflammatory parameters and physical performance in elderly women. Age (Dordrecht, Netherlands). 2013 Dec;35(6):2455–2463. PubMed PMID: 23430759; PubMed Central PMCID: PMCPmc3824985.
   PubMedGoogle Scholar
• Lucassen PJ, Meerlo P, Naylor AS, et al. Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: implications for depression and antidepressant action. European Neuropsychopharmacology. 2010 Jan;20(1):1–17. PubMed PMID: 19748235.
   PubMed Web of Science ®Google Scholar
• Eyre H, Baune BT. Neuroimmunological effects of physical exercise in depression. Brain Behav Immun. 2012 Feb;26(2):251–266. PubMed PMID: 21986304. DOI:10.1016/j.bbi.2011.09.015.
   PubMed Web of Science ®Google Scholar
• Gleeson M, Bishop NC, Stensel DJ, et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011 Aug 05;11(9):607–615. PubMed PMID: 21818123.
   PubMed Web of Science ®Google Scholar
• Martinsen EW, Hoffart A, Solberg O. Comparing aerobic with nonaerobic forms of exercise in the treatment of clinical depression: a randomized trial. Compr Psychiatry. 1989 Jul-Aug;30(4):324–331. PubMed PMID: 2667882.
   PubMed Web of Science ®Google Scholar
• Dimeo F, Bauer M, Varahram I, et al. Benefits from aerobic exercise in patients with major depression: a pilot study. Br J Sports Med. 2001 Apr;35(2):114–117. PubMed PMID: 11273973; PubMed Central PMCID: PMCPmc1724301.
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Greer TL, Grannemann BD, et al. Exercise as an augmentation strategy for treatment of major depression. J Psychiatr Pract. 2006 Jul;12(4):205–213. PubMed PMID: 16883145.
   PubMedGoogle Scholar
• Trivedi MH, Greer TL, Church TS, et al. Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. J Clin Psychiatry. 2011 May;72(5):677–684. PubMed PMID: 21658349.
   PubMed Web of Science ®Google Scholar
• Schuch FB, Vancampfort D, Rosenbaum S, et al. Exercise improves physical and psychological quality of life in people with depression: a meta-analysis including the evaluation of control group response. Psychiatry Res. 2016 Jul 30;241:47–54. PubMed PMID: 27155287. DOI:10.1016/j.psychres.2016.04.054.
   PubMed Web of Science ®Google Scholar
• Ng F, Dodd S, Berk M. The effects of physical activity in the acute treatment of bipolar disorder: a pilot study. J Affect Disord. 2007 Aug;101(1–3):259–262. PubMed PMID: 17182104. DOI:10.1016/j.jad.2006.11.014.
   PubMed Web of Science ®Google Scholar
• Knubben K, Reischies FM, Adli M, et al. A randomised, controlled study on the effects of a short-term endurance training programme in patients with major depression. Br J Sports Med. 2007 Jan;41(1):29–33. PubMed PMID: 17062659; PubMed Central PMCID: PMCPmc2465130.
   PubMed Web of Science ®Google Scholar
• Bercik P, Verdu EF, Foster JA, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010 Dec;139(6):2102–2112.e1. PubMed PMID: 20600016.
   PubMed Web of Science ®Google Scholar
• Bravo JA, Dinan TG, Cryan JF. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. Int J Neuropsychopharmacol. 2011 Jun;14(5):666–683. PubMed PMID: 20860876. DOI:10.1017/s1461145710000994.
   PubMed Web of Science ®Google Scholar
• Bercik P, Collins SM, Verdu EF. Microbes and the gut-brain axis. Neurogastroenterol Motil. 2012 May;24(5):405–413. PubMed PMID: 22404222. DOI:10.1111/j.1365-2982.2012.01906.x.
   PubMed Web of Science ®Google Scholar
• Wallace CJK, Milev R. Erratum to: the effects of probiotics on depressive symptoms in humans: a systematic review. Ann Gen Psychiatry. 2017;16:18. PubMed PMID: 28286538; PubMed Central PMCID: PMCPmc5341395. DOI:10.1186/s12991-017-0141-7.
   PubMed Web of Science ®Google Scholar
• Ait-Belgnaoui A, Durand H, Cartier C, et al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology. 2012 Nov;37(11):1885–1895. PubMed PMID: 22541937.
   PubMed Web of Science ®Google Scholar
• Luo J, Wang T, Liang S, et al. Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat. Sci China Life Sci. 2014 Mar;57(3):327–335. PubMed PMID: 24554471.
   PubMed Web of Science ®Google Scholar
• Ait-Belgnaoui A, Colom A, Braniste V, et al. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol Motil. 2014 Apr;26(4):510–520. PubMed PMID: 24372793.
   PubMed Web of Science ®Google Scholar
• Desbonnet L, Garrett L, Clarke G, et al. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010 Nov 10;170(4):1179–1188. PubMed PMID: 20696216.
   PubMed Web of Science ®Google Scholar
• Marin IA, Goertz JE, Ren T, et al. Microbiota alteration is associated with the development of stress-induced despair behavior. Scientific Reports. 2017 Mar 7;07:43859. PubMed PMID: 28266612; PubMed Central PMCID: PMC5339726. DOI:10.1038/srep43859.
   Google Scholar
• Messaoudi M, Violle N, Bisson JF, et al. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes. 2011 Jul-Aug;2(4):256–261. PubMed PMID: 21983070.
   PubMed Web of Science ®Google Scholar
• Rao AV, Bested AC, Beaulne TM, et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathogens. 2009 Mar 19;1(1):6. PubMed PMID: 19338686; PubMed Central PMCID: PMCPmc2664325.
   PubMed Web of Science ®Google Scholar
• Huang R, Wang K, Hu J. Effect of probiotics on depression: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2016 Aug 06;8(8). PubMed PMID: 27509521; PubMed Central PMCID: PMCPmc4997396. DOI:10.3390/nu8080483.
   Web of Science ®Google Scholar
• Munoz-Elias G, Woodbury D, Black IB. Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions. Stem Cells. 2003;21(4):437–448. PubMed PMID: 12832697. DOI:10.1634/stemcells.21-4-437.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999 Apr 02;284(5411):143–147. PubMed PMID: 10102814.
   PubMed Web of Science ®Google Scholar
• Salem H, Rocha NP, Colpo GD, et al. Moving from the dish to the clinical practice: a decade of lessons and perspectives from the pre-clinical and clinical stem cell studies for Alzheimer’s disease. J Alzheimers Dis: JAD. 2016 Jul 2. PubMed PMID: 27392861. DOI:10.3233/JAD-160250.
   PubMedGoogle Scholar
• Colpo GD, Ascoli BM, Wollenhaupt-Aguiar B, et al. Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders. An Acad Bras Cienc. 2015 Aug;87(2 Suppl):1435–1449. PubMed PMID: 26247151.
   PubMed Web of Science ®Google Scholar
• Tfilin M, Sudai E, Merenlender A, et al. Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior. Mol Psychiatry. 2010 Dec;15(12):1164–1175. PubMed PMID: 19859069; eng. DOI:10.1038/mp.2009.110.
   PubMed Web of Science ®Google Scholar
• Coquery N, Blesch A, Stroh A, et al. Intrahippocampal transplantation of mesenchymal stromal cells promotes neuroplasticity. Cytotherapy. 2012 Oct;14(9):1041–1053. PubMed PMID: 22762522.
   PubMed Web of Science ®Google Scholar
• Wiedlocha M, Marcinowicz P, Krupa R, et al. Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 23. PubMed PMID: 28445690. DOI:10.1016/j.pnpbp.2017.04.026.
   PubMed Web of Science ®Google Scholar
• Rapaport MH, Manji HK. The effects of lithium on ex vivo cytokine production. Biol Psychiatry. 2001 Aug 01;50(3):217–224. PubMed PMID: 11513821.
   PubMed Web of Science ®Google Scholar
• Bosetti F, Rintala J, Seemann R, et al. Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain. Mol Psychiatry. 2002;7(8):845–850. PubMed PMID: 12232777. DOI:10.1038/sj.mp.4001111.
   PubMed Web of Science ®Google Scholar
• Himmerich H, Schonherr J, Fulda S, et al. Impact of antipsychotics on cytokine production in-vitro. J Psychiatr Res. 2011 Oct;45(10):1358–1365. PubMed PMID: 21592521.
   PubMed Web of Science ®Google Scholar
• Aan Het Rot M, Zarate CA Jr., Charney DS, et al. Ketamine for depression: where do we go from here? Biol Psychiatry. 2012 Oct 01;72(7):537–547. PubMed PMID: 22705040; PubMed Central PMCID: PMCPmc3438349.
   PubMed Web of Science ®Google Scholar
• Yang C, Hong T, Shen J, et al. Ketamine exerts antidepressant effects and reduces IL-1beta and IL-6 levels in rat prefrontal cortex and hippocampus. Exp Ther Med. 2013 Apr;5(4):1093–1096. PubMed PMID: 23596475; PubMed Central PMCID: PMCPmc3627439.
   PubMed Web of Science ®Google Scholar
• Dale O, Somogyi AA, Li Y, et al. Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis. Anesth Analg. 2012 Oct;115(4):934–943. PubMed PMID: 22826531.
   PubMed Web of Science ®Google Scholar
• Wang N, Yu HY, Shen XF, et al. The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus. Ups J Med Sci. 2015;120(4):241–248. PubMed PMID: 26220286; PubMed Central PMCID: PMCPmc4816884. DOI:10.3109/03009734.2015.1060281.
   PubMed Web of Science ®Google Scholar
• Zunszain PA, Horowitz MA, Cattaneo A, et al. Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties. Mol Psychiatry. 2013 Dec;18(12):1236–1241. PubMed PMID: 23877835; PubMed Central PMCID: PMCPmc3835937.
   PubMed Web of Science ®Google Scholar
• Walker AK, Budac DP, Bisulco S, et al. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology. 2013 Aug;38(9):1609–1616. PubMed PMID: 23511700; PubMed Central PMCID: PMC3717543.
   PubMed Web of Science ®Google Scholar
• Kronfol Z, Hamdan-Allen G, Goel K, et al. Effects of single and repeated electroconvulsive therapy sessions on plasma ACTH, prolactin, growth hormone and cortisol concentrations. Psychoneuroendocrinology. 1991;16(4):345–352. PubMed PMID: 1660606.
   PubMed Web of Science ®Google Scholar
• Fluitman SB, Heijnen CJ, Denys DA, et al. Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. J Affect Disord. 2011 Jun;131(1–3):388–392. PubMed PMID: 21183225.
   PubMed Web of Science ®Google Scholar
• Lehtimaki K, Keranen T, Huuhka M, et al. Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J Ect. 2008 Mar;24(1):88–91. PubMed PMID: 18379341.
   PubMed Web of Science ®Google Scholar
• Hestad KA, Tonseth S, Stoen CD, et al. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J Ect. 2003 Dec;19(4):183–188. PubMed PMID: 14657769.
   PubMed Web of Science ®Google Scholar
• Freire TFV, Rocha NSD, Fleck MPA. The association of electroconvulsive therapy to pharmacological treatment and its influence on cytokines. J Psychiatr Res. 2017 Sep;92:205–211. PubMed PMID: 28521271.
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Ferrucci R, Fregni F, et al. Transcranial direct current stimulation for the treatment of major depressive disorder: a summary of preclinical, clinical and translational findings. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 01;39(1):9–16. PubMed PMID: 22651961.
   PubMed Web of Science ®Google Scholar
• Nitsche MA, Cohen LG, Wassermann EM, et al. Transcranial direct current stimulation: state of the art 2008. Brain Stimul. 2008 Jul;1(3):206–223. PubMed PMID: 20633386.
   PubMed Web of Science ®Google Scholar
• Spezia Adachi LN, Caumo W, Laste G, et al. Reversal of chronic stress-induced pain by transcranial direct current stimulation (tDCS) in an animal model. Brain Res. 2012 Dec 13;1489:17–26. PubMed PMID: 23063889. DOI:10.1016/j.brainres.2012.10.009.
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Machado-Vieira R, Zarate CA, et al. Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial. Psychopharmacology. 2014 Apr;231(7):1315–1323. PubMed PMID: 24150249; PubMed Central PMCID: PMCPmc4081040.
   PubMed Web of Science ®Google Scholar
• Benabid AL, Benazzous A, Pollak P. Mechanisms of deep brain stimulation. Mov Disord. 2002;17(Suppl 3):S73–4. PubMed PMID: 11948758.
   PubMed Web of Science ®Google Scholar
• Lozano AM, Giacobbe P, Hamani C, et al. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg. 2012 Feb;116(2):315–322. PubMed PMID: 22098195.
   PubMed Web of Science ®Google Scholar
• Calleja-Castillo JM, De La Cruz-Aguilera DL, Manjarrez J, et al. Chronic deep brain stimulation of the hypothalamic nucleus in wistar rats alters circulatory levels of corticosterone and proinflammatory cytokines. Clin Dev Immunol. 2013;2013:698634. PubMed PMID: 24235973; PubMed Central PMCID: PMCPmc3819891. DOI:10.1155/2013/698634.
   PubMedGoogle Scholar